Urinalysis Market Size, Share, Industry, Forecast and outlook (2024-2031)

Global Urinalysis Market Size, Share & Trends Analysis Report By Product (Instruments, Semi-Automated Urine Analyzers, Automated Urine Analyzers, Consumables , Disposables , Dipsticks, Reagents & Kits, Others), By Test Type (Pregnancy & Fertility Tests, Sediment Urinalysis, Biochemical Urinalysis , Point-Of-Care Tests and Laboratory Tests), By Application (Urinary Tract Infections, Diabetes, Kidney Diseases, Liver Diseases, Others), By End-User (Hospitals, Home Care Settings, Diagnostic Laboratories, Research Laboratories & Academic Institutes, Others), By Region (North America, Europe, South America, Asia-Pacific & Middle East and Africa), And Segment Forecasts, 2024 – 2031

Market Overview

The global urinalysis market reached US$ 3.60 billion in 2023 and is expected to reach US$ 6.08 billion by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

A urinalysis is a test of your urine test that can assess many different aspects of your health with a urine sample. It's used to detect and manage a wide range of disorders, such as urinary tract infections, kidney disease, and diabetes. 

A urinalysis involves checking the appearance, concentration, and content of urine. For example, a urinary tract infection can make urine look cloudy instead of clear. Increased levels of protein in urine can be a sign of kidney disease. It plays a crucial role in the early detection and management of diseases, making it an essential diagnostic tool for healthcare professionals worldwide.

The major key factors driving the market are the rising prevalence of urinary tract infections & urological disorders, the growing geriatric population & the burden of chronic kidney diseases, the rising preference for point-of-care testing, and technological advancements in the healthcare industry.

Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Rising Prevalence of Urinary Tract Infections & Urological Disorders 

The demand for the global urinalysis market is driven by multiple factors. One of the key factors is the rising prevalence of UTI & urological disorders. Urinary tract infections (UTIs) are one of the most common infections worldwide. 

As per BMC Infectious Disease publication in October 2023, urinary tract infection (UTI) is the second most common infectious disease affecting more than 150 million people globally annually. Uropathogenic E. coli (UPEC), the predominant cause of UTI, can occur as a biofilm-associated with antimicrobial resistance (AMR).

Urine particle analysis &  urine sediment testing is an important test used to diagnose renal and urinary tract disorders. This test is conducted by classifying and measuring particles formed in urine, such as red blood cells, white blood cells, and bacteria.

Moreover, key players in the industry technological innovations such as AI in UTI treatment help to drive this market growth. For instance, in January 2024, Zoetis Inc., announced the expansion of its multi-application diagnostics platform, Vetscan Imagyst, to include AI Urine Sediment analysis. The new application will enable accurate, in-clinic sediment analysis of fresh urine, allowing clinicians to make treatment decisions quickly.

Also, in January 2023, Starling Medical’s new urine-testing device turns your toilet into a health tracker. Using some AI and spectroscopy sensors, the catheter would track the urine still in a patient’s bladder to detect urinary tract infections, which can lead to hospitalizations and sepsis.

Restraints

Factors such as the high cost of urinalysis tests & equipment, stringent regulatory approval process, complexity of urinalysis testing  & interpretation, limited awareness & lack of education among healthcare professionals, and limited reimbursement policies are expected to hamper the market.

Segment Analysis

The global urinalysis market is segmented based on product, test type, application, end-user, and region.

The instruments segment accounted for approximately 43.3% of the  global urinalysis market share

The instruments segment is expected to hold the largest market share over the forecast period. A urine analyzer is a device used in the clinical setting to perform automatic urine testing. The units can detect and quantify several analytes including bilirubin, protein, glucose, and red blood cells. Many models contain urine strip readers, a type of reflectance photometer that can process several hundred strips per hour.

In addition, major players in the industry launching new analyzers for UTI infections would propel this segment's growth. For instance, in December 2023, Siemens Healthineers now offer high-resolution, digital urine microscopy with its compact Atellica UAS 60 analyzer. 

This is a compact solution for urine sediment analysis, that can automate a lab's urinalysis workflow with full field-of-view digital imaging that closely replicates manual microscopy. Laboratory professionals can more rapidly and accurately review and report urine sediment results by replacing routine manual microscopy with an automated, digital alternative.

Similarly, in April 2023, Sysmex Europe launched the UF-1500 Fully Automated Urine Particle Analyser (UF-1500), a new product for use in particle analysis. The UF-1500 inherits the high levels of functionality and usability of the UF-5000 Fully Automated Urine Particle Analyser (UF-5000), our flagship model in urine particle analysis while achieving a downsizing of the former model. 

Geographical Analysis

North America accounted for approximately 45.6% of the global urinalysis  market share 

North America region is expected to hold the largest market share over the forecast period owing to the rising prevalence of  UTI cases helping to drive this market growth. As per Medscape U.S. statistics in February 2024, UTIs in women are very common in the U.S., approximately 25-40% of women in the United States aged 20-40 years have had a UTI.

Furthermore, in this region, a major key player's presence, well-developed healthcare infrastructure, and innovative developments, urine test approvals would propel this market growth. For instance, in January 2023, Withings announced U-Scan, the world's first hands-free connected home urine lab. 

Sophisticated urine analysis allows users to monitor metabolic insights and empowers women to manage monthly cycles ability of U-Scan to perform daily urine analysis from the home will allow Withings to take its mission to help consumers fully utilize urine data to an entirely new level.

Similarly, in October 2023, the Food and Drug Administration cleared for marketing the first over-the-counter test to detect fentanyl in urine.

Market Segmentation

By Product 

• Instruments 

• Semi-Automated Urine Analyzers
• Automated Urine Analyzers

•  Consumables 

• Disposables 
• Dipsticks
• Reagents & Kits
• Others

By Test Type 

• Pregnancy & Fertility Tests
• Sediment Urinalysis
• Biochemical Urinalysis 

• Point-Of-Care Tests
• Laboratory Tests

By Application 

• Urinary Tract Infections
• Diabetes
• Kidney Diseases
• Liver Diseases
• Others

 By End-User 

• Hospitals
• Home Care Settings
• Diagnostic Laboratories
• Research Laboratories & Academic Institutes
•  Others

By Region

• North America

• U.S.
• Canada
• Mexico

• Europe

• Germany
• U.K.
• France
• Spain
• Italy
• Rest of Europe

• South America

• Brazil
• Argentina
• Rest of South America

• Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

• Middle East and Africa

Competitive Landscape

The major global players in the urinalysis market include Abbott, Siemens Healthcare Private Limited, BD, Thermo Fisher Scientific, 77 Elektronika Kft, F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Sysmex, ACON Laboratories Inc, and Analyticon Biotechnologies GmbH among others.

Key Developments

• In January 2024, Una Health Ltd was delighted to unveil the new, enhanced model of the Urisys 1100 Urine Analyser from Roche Diagnostics. Boasting a sleek and compact design, the Urisys 1100 stands out as one of the smallest and lightest devices in its class, designed for fast, safe, and accurate urinalysis.
• In August 2023, Signify Health launches in-home testing for chronic kidney disease. It is expanding its services with the addition of a new in-home testing option for chronic kidney disease.
• In February 2023, Sysmex introduced automated urinalysis testing solutions that revolutionized workflow at Medlab Middle East 2023. It presents its broad range of medical diagnostics products and solutions in the fields of hematology, urinalysis, hemostasis, and flow cytometry.
• In January 2023, Vivoo announced the launch of the world's first smart toilet clip-on device that will help in the early detection of health conditions. The toilet is a game-changer for healthcare and caring professionals, enabling users to perform urine testing and receive personalized wellness, health, and nutritional recommendations without the mess.

Why Purchase the Report?

• To visualize the global urinalysis market segmentation based on product, test type, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of global urinalysis market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.

The global urinalysis market report would provide approximately 70 tables, 72 figures, and 182 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Trending Topics:

Hospital Acquired Infections Market

Metabolomics Market

Renal Biomarkers Market